Literature DB >> 1089843

Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. II. Influence of medication with prednisone and azathioprine: a histologic and immunohistologic study at the light microscopic and the ultrastructural level.

K Feenstra, R van den Lee, H A Greben, A Arends, P J Hoedemaeker.   

Abstract

In this paper, the effect of the administration of prednisone and azathioprine on an experimental immune complex glomerulonephritis is studied. During the observation period of 3 months, it appeared that prednisone had no effect either on the morphology of glomerulonephritis or on the proteinuria caused by it. Azathioprine, especially when given 4 days before or simultaneously with the induction of the experimental immune complex glomerulonephritis, showed a clear effect on the morphology of the glomerulonephritis as well as on the proteinuria. The damage to the glomerular basement membrane as a result of deposition of immune complexes was less and the proteinuria was significantly lower. The effect of azathioprine was not present when given 10 days after the induction of glomerulonephritis, at a time when the autologous phase had already developed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1089843

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  3 in total

1.  Triple-drug treatment of autologous immune complex glomerulonephritis.

Authors:  G J Fleuren; P J Hoedemaeker
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

2.  Effects of aspirin, prednisolone and indomethacin on nephrotoxic serum nephritis in the rat.

Authors:  H Kurokawa; K Sakamoto
Journal:  Br J Pharmacol       Date:  1982-01       Impact factor: 8.739

3.  Proteolytic enzyme treatment reduces glomerular immune deposits and proteinuria in passive Heymann nephritis.

Authors:  M Nakazawa; S N Emancipator; M E Lamm
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.